Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-03

Clinical Trial Update: Prospective Observational Study for Determination of Minimal Clinically Important Difference of Allergic Rhinitis Symptoms Due to Grass Pollen (Equinoxe 2)

View source ↗

Summary

Observed completed prospective study (Equinoxe 2) to determine the minimal clinically important difference of allergic rhinitis symptoms caused by grass pollen,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hopital Foch | Conditions: Allergic Rhinitis Due to Grass Pollen | Status: COMPLETED